
Sign up to save your podcasts
Or
We're talking with Dr. Kratz about how My MS Toolkit was developed and what makes it such a powerful online tool for people living with MS.
We're also talking about the latest petitions filed with the Supreme Court in the battle over the Affordable Care Act (and why this is so vitally important to people affected by MS!). If you're using gabapentin (Neurontin) to manage MS pain, we'll tell you about the warning that was just issued by the FDA.
Yet another study gives us yet another reason to start disease-modifying therapy as soon as possible. And we'll explain why collecting real-world data about MS is so important, and what a team of MS experts is recommending to improve the process of real-world data collection and analysis.
We have a lot to talk about! Are you ready for RealTalk MS??! ___________ Where I'll Be in January :27National MS Society Joins 23 Other Patient Organizations in Requesting Supreme Court Expedites Its Review of the ACA 3:00
FDA Issues Warning About Gabapentinoids 6:51
Disease-Modifying Therapy Use Has Changed the 'Natural History' of Relapsing-Remitting MS 7:57
Paper Explores How Real-World Data Can Be Better Leveraged to Speed Solutions to People Living with MS 9:34
My Interview with Dr. Anna Kratz 15:04
Share This Episode 36:00
Download the RealTalk MS App 36:29
___________
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: http://realtalkms.com/123
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
My MS Toolkit
FDA Warns About Serious Breathing Problems when Gabapentin and Pregabalin Are Used With CNS Depressants or By Patients with Lung Problems
STUDY: Outcomes in a Modern Cohort of Treated Multiple Sclerosis Patients Followed from Diagnosis Up to 15 Years
Leveraging Real-World Data to Investigate Multiple Sclerosis Disease Behavior, Prognosis, and Treatment
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 123 Hosted By: Jon Strum Guests: Dr. Anna Kratz
Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Gabapentinoids, ACA, RealTalkMS
Privacy Policy
4.7
137137 ratings
We're talking with Dr. Kratz about how My MS Toolkit was developed and what makes it such a powerful online tool for people living with MS.
We're also talking about the latest petitions filed with the Supreme Court in the battle over the Affordable Care Act (and why this is so vitally important to people affected by MS!). If you're using gabapentin (Neurontin) to manage MS pain, we'll tell you about the warning that was just issued by the FDA.
Yet another study gives us yet another reason to start disease-modifying therapy as soon as possible. And we'll explain why collecting real-world data about MS is so important, and what a team of MS experts is recommending to improve the process of real-world data collection and analysis.
We have a lot to talk about! Are you ready for RealTalk MS??! ___________ Where I'll Be in January :27National MS Society Joins 23 Other Patient Organizations in Requesting Supreme Court Expedites Its Review of the ACA 3:00
FDA Issues Warning About Gabapentinoids 6:51
Disease-Modifying Therapy Use Has Changed the 'Natural History' of Relapsing-Remitting MS 7:57
Paper Explores How Real-World Data Can Be Better Leveraged to Speed Solutions to People Living with MS 9:34
My Interview with Dr. Anna Kratz 15:04
Share This Episode 36:00
Download the RealTalk MS App 36:29
___________
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: http://realtalkms.com/123
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
My MS Toolkit
FDA Warns About Serious Breathing Problems when Gabapentin and Pregabalin Are Used With CNS Depressants or By Patients with Lung Problems
STUDY: Outcomes in a Modern Cohort of Treated Multiple Sclerosis Patients Followed from Diagnosis Up to 15 Years
Leveraging Real-World Data to Investigate Multiple Sclerosis Disease Behavior, Prognosis, and Treatment
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 123 Hosted By: Jon Strum Guests: Dr. Anna Kratz
Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Gabapentinoids, ACA, RealTalkMS
Privacy Policy
1,184 Listeners
2,996 Listeners
3,281 Listeners
12,937 Listeners
12,543 Listeners
711 Listeners
3,167 Listeners
13 Listeners
41 Listeners
14,525 Listeners
616 Listeners
109 Listeners
10,781 Listeners
3,442 Listeners
1,056 Listeners